LYST and cancer: In almost all cancers, CHS3 exhibited more active cell proliferation, metastasis, immune destruction, and angiogenesis, whereas CHS1 had stronger ability to evading growth inhibition and dysregulation of energy metabolism (Figure 6B, Figure S9).